GEHC Competitors
| GEHC Stock | 79.08 1.57 1.95% |
GE HealthCare vs Koninklijke Philips Correlation
Good diversification
The correlation between GE HealthCare Technologies and PHG is -0.04 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding GE HealthCare Technologies and PHG in the same portfolio, assuming nothing else is changed.
Moving against GEHC Stock
| 0.86 | IVF | INVO Fertility Symbol Change | PairCorr |
| 0.77 | OTC | Ocumetics Technology Corp | PairCorr |
| 0.6 | IHC | Inspiration Healthcare | PairCorr |
| 0.57 | AHC | Austco Healthcare | PairCorr |
| 0.44 | AHG | Akso Health Group | PairCorr |
GE HealthCare Competition Correlation Matrix
Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between GE HealthCare and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of GEHC and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of GE HealthCare Techno does not affect the price movement of the other competitor.
High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between GEHC Stock performing well and GE HealthCare Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze GE HealthCare's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| HUM | 2.16 | (0.68) | 0.00 | (0.34) | 0.00 | 3.79 | 27.31 | |||
| IQV | 1.44 | (0.25) | 0.00 | (0.08) | 0.00 | 3.30 | 15.97 | |||
| CAH | 1.02 | 0.26 | 0.10 | (0.63) | 1.14 | 2.54 | 10.21 | |||
| INSM | 1.88 | (0.27) | 0.00 | 4.28 | 0.00 | 2.84 | 20.19 | |||
| ALC | 1.09 | 0.09 | 0.01 | 0.90 | 1.03 | 3.24 | 7.05 | |||
| ONC | 1.96 | 0.14 | 0.06 | 0.26 | 1.78 | 4.39 | 14.16 | |||
| RMD | 1.06 | 0.11 | 0.06 | 0.23 | 1.13 | 2.13 | 5.71 | |||
| A | 1.21 | (0.31) | 0.00 | (0.16) | 0.00 | 2.90 | 7.85 | |||
| MTD | 1.08 | (0.14) | 0.00 | (0.04) | 0.00 | 2.51 | 7.69 | |||
| PHG | 1.13 | (0.02) | 0.00 | 0.07 | 1.70 | 2.43 | 8.74 |
Cross Equities Net Income Analysis
Compare GE HealthCare Techno and related stocks such as Humana Inc, IQVIA Holdings, and Cardinal Health Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IQV | 160.6 M | 241.8 M | 177.5 M | 226.6 M | 356.4 M | 387.2 M | 115 M | 1.3 B | 259 M | 191 M | 279 M | 966 M | 1.1 B | 1.4 B | 1.4 B | 1.4 B | 1.4 B |
| CAH | 6 M | 1.1 B | 334 M | 1.2 B | 1.2 B | 1.4 B | 1.3 B | 256 M | 1.4 B | (3.7 B) | 611 M | (938 M) | 330 M | 852 M | 1.6 B | 1.8 B | 1.9 B |
| INSM | (7.8 M) | (59.7 M) | (41.4 M) | (56.1 M) | (79.2 M) | (118.2 M) | (176.3 M) | (192.6 M) | (324.3 M) | (254.3 M) | (294.1 M) | (434.7 M) | (481.5 M) | (749.6 M) | (913.8 M) | (822.4 M) | (781.3 M) |
| ALC | 931 M | 296.3 M | 296.3 M | 296.3 M | 296.3 M | 296.3 M | (170 M) | 256 M | (227 M) | (656 M) | (531 M) | 376 M | 335 M | 974 M | 1 B | 916.2 M | 962 M |
| ONC | (7.5 M) | (7.5 M) | (7.5 M) | (7.5 M) | (18.3 M) | (57.1 M) | (119.2 M) | (93.1 M) | (673.8 M) | (948.6 M) | (1.6 B) | (1.5 B) | (2 B) | (881.7 M) | (644.8 M) | (580.3 M) | (609.3 M) |
| RMD | 800 K | 254.8 M | 307.1 M | 345.3 M | 352.9 M | 352.4 M | 342.3 M | 315.6 M | 404.6 M | 621.7 M | 474.5 M | 779.4 M | 897.6 M | 1 B | 1.4 B | 1.6 B | 1.7 B |
| A | 257 M | 1.2 B | 724 M | 549 M | 401 M | 460 M | 684 M | 316 M | 1.1 B | 719 M | 1.2 B | 1.3 B | 1.2 B | 1.3 B | 1.3 B | 1.5 B | 1.6 B |
| MTD | (65.9 M) | 269.5 M | 290.8 M | 306.1 M | 338.2 M | 352.8 M | 384.4 M | 376 M | 512.6 M | 561.1 M | 602.7 M | 769 M | 872.5 M | 788.8 M | 863.1 M | 869.2 M | 912.7 M |
| PHG | 234.6 M | (1.3 B) | 226 M | 1.2 B | 415 M | 645 M | 1.4 B | 1.7 B | 1.1 B | 1.2 B | 1.2 B | 3.3 B | (1.6 B) | (466 M) | (702 M) | (631.8 M) | (600.2 M) |
GE HealthCare Techno and related stocks such as Humana Inc, IQVIA Holdings, and Cardinal Health Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in GE HealthCare Techno financial statement analysis. It represents the amount of money remaining after all of GE HealthCare Technologies operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.GE HealthCare Competitive Analysis
The better you understand GE HealthCare competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, GE HealthCare's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across GE HealthCare's competition over several years is one of the best ways to analyze its investment potential.| Better Than Average | Worse Than Peers | View Performance Chart |
GE HealthCare Competition Performance Charts
Five steps to successful analysis of GE HealthCare Competition
GE HealthCare's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by GE HealthCare Techno in relation to its competition. GE HealthCare's competition analysis typically involves several steps, including:- Identifying the key players in the market: This involves identifying the major competitors of GE HealthCare in the market, both direct and indirect, as well as new entrants and disruptive technologies.
- Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
- Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact GE HealthCare's competitive landscape.
- Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to GE HealthCare Techno, and developing a strategy to address them.
- Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Complement your GE HealthCare position
In addition to having GE HealthCare in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Real Estate ETFs Thematic Idea Now
Real Estate ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Real Estate ETFs theme has 69 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Real Estate ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out GE HealthCare Correlation with its peers. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Will Health Care Equipment & Supplies sector continue expanding? Could GEHC diversify its offerings? Factors like these will boost the valuation of GE HealthCare. Market participants price GEHC higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every GE HealthCare data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth (0.18) | Dividend Share 0.14 | Earnings Share 4.55 | Revenue Per Share | Quarterly Revenue Growth 0.071 |
The market value of GE HealthCare Techno is measured differently than its book value, which is the value of GEHC that is recorded on the company's balance sheet. Investors also form their own opinion of GE HealthCare's value that differs from its market value or its book value, called intrinsic value, which is GE HealthCare's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because GE HealthCare's market value can be influenced by many factors that don't directly affect GE HealthCare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between GE HealthCare's value and its price as these two are different measures arrived at by different means. Investors typically determine if GE HealthCare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, GE HealthCare's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.